Metraipolis › archive › dc_551bfa78fa9c
Dual therapy with allicin and metformin provides superior cardioprotection against doxorubicin-induced cardiotoxicity in rats compared to monotherapy — Europe PMC PMID:41585873
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41585873
- DOI
- 10.3389/fphar.2025.1725943
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-06T22:46:28.630Z
- SHA-256 of the archived text
52f968b3adf87e9746b319807eadd01addde893abb8f2518e1b5f47abdedd81a- Stable URL of this page
https://metraipolis.com/documento/dc_551bfa78fa9c
How to cite
Dual therapy with allicin and metformin provides superior cardioprotection against doxorubicin-induced cardiotoxicity in rats compared to monotherapy — Europe PMC PMID:41585873 — Europe PMC (en), https://europepmc.org/article/MED/41585873 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_551bfa78fa9c (Metraipolis archive dc_551bfa78fa9c, sha256 52f968b3adf87e9746b319807eadd01addde893abb8f2518e1b5f47abdedd81a)
BibTeX
@misc{dc551bfa78fa9c,
title = {Dual therapy with allicin and metformin provides superior cardioprotection against doxorubicin-induced cardiotoxicity in rats compared to monotherapy — Europe PMC PMID:41585873},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41585873},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_551bfa78fa9c; sha256 52f968b3adf87e9746b319807eadd01addde893abb8f2518e1b5f47abdedd81a},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41585873. Agents can read the archived copy with the MCP tool read_document.